Literature DB >> 4051274

Noninvasive vascular studies in management of rattlesnake envenomations to extremities.

S C Curry, J C Kraner, D B Kunkel, P J Ryan, M V Vance, R K Requa, S B Ruggeri.   

Abstract

Twenty-five consecutive patients suffering rattlesnake envenomation to an extremity underwent noninvasive vascular arterial studies using contralateral extremities as controls. All but one received antivenin, and none underwent early surgical decompression. Pulse volume amplitudes in the envenomated extremities, reflecting pulsatile arterial blood flow, were increased in 24 of 25 patients (P less than .02) in spite of edema and discoloration. Ischemia requiring surgical procedures developed in three of seven patients with decreased skin temperatures, as compared to none of 18 with increased or mixed skin temperatures on the envenomated extremity (P less than .02). One of 24 survivors suffered a functional deficit. Most victims of rattlesnake bites have increased arterial pulsatile blood flow in an envenomated extremity and do well with medical therapy. Noninvasive arterial studies help select those who are more likely to require special surgical intervention.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4051274     DOI: 10.1016/s0196-0644(85)80926-4

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  2 in total

1.  Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop.

Authors:  Eric J Lavonas; Anne-Michelle Ruha; William Banner; Vikhyat Bebarta; Jeffrey N Bernstein; Sean P Bush; William P Kerns; William H Richardson; Steven A Seifert; David A Tanen; Steve C Curry; Richard C Dart
Journal:  BMC Emerg Med       Date:  2011-02-03

2.  A Multidisciplinary Approach with Hyperbaric Oxygen Therapy Improve Outcome in Snake Bite Injuries.

Authors:  Pradeoth Mukundan Korambayil; Prashanth Varkey Ambookan; Siju Varghese Abraham; Ajay Ambalakat
Journal:  Toxicol Int       Date:  2015 Jan-Apr
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.